Stockreport

Vigil Neuroscience to Present at Guggenheim Securities SMID Cap Biotech Conference

Vigil Neuroscience, Inc.  (VIGL) 
PDF WATERTOWN, Mass., Jan. 30, 2025 (GLOBE NEWSWIRE) -- Vigil Neuroscience, Inc. (Nasdaq: VIGL), a clinical-stage biotechnology company committed to harnessing the power o [Read more]